🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Pee Safe raises $32 Mn led by OrbiMed

EntrackrEntrackr · 22h ago
Pee Safe raises $32 Mn led by OrbiMed
Medial

Pee Safe raises $32 Mn led by OrbiMed Women’s hygiene and wellness brand Pee Safe has raised $32 million in a funding round led by global healthcare-focused private equity firm OrbiMed. The round included both primary capital and partial exits for some early investors. Pee Safe has raised $45.55 million in funding to date, with Alkemi Partners as its lead investor. The fresh capital will be used to expand offline retail presence, strengthen distribution, and scale sales across marketplaces and quick commerce platforms. Launched in 2017 by Vikas Bagaria and Srijana Bagaria, Pee Safe operates in the personal hygiene and wellness segment with products spanning intimate hygiene, menstrual care, and sanitisation. Pee Safe has steadily expanded its product portfolio and distribution footprint across online and offline channels in India. Pee Safe generates revenue primarily from sales of sanitary, personal hygiene, and intimate care products across online marketplaces, offline retail, and its direct-to-consumer channels. As per TheKredible, the Gurugram-based company's revenue from operations grew 46% to Rs 82 crore in FY25 from Rs 56 crore in FY24. It managed to curb its losses by 69% to Rs 4 crore in FY25 from Rs 13 crore in FY24.

Pee Safe reports Rs 82 Cr revenue in FY25, nears breakeven

EntrackrEntrackr · 9d ago
Pee Safe reports Rs 82 Cr revenue in FY25, nears breakeven
Medial

Pee Safe improved its financial performance in FY25 as the company continued to scale while tightening its cost structure. The Gurugram-based firm reduced its losses by nearly 70% during the fiscal year ending March 2025. Pee Safe’s revenue from operations grew 46% to Rs 82 crore in FY25 from Rs 56 crore in FY24, as per its financial statements filed with the Registrar of Companies (RoC). Launched in 2013 by Vikas Bagaria and Srijana Bagaria, Pee Safe generates revenue primarily from sales of sanitary, personal hygiene, and intimate care products across online marketplaces, offline retail, and its direct-to-consumer channels. Revenue from these products was the sole source of revenue for the company. Cost of materials remained the largest cost component for the company, forming around 31% of total expenditure. This cost rose 29% to Rs 27 crore in FY25. Advertising and promotional spending, the second largest cost head, increased 16% to Rs 26 crore. Employee benefit expenses went up 18% to Rs 13 crore, while commission and freight costs stood at Rs 5 crore each. Overall, Pee Safe’s total expense increased 24% to Rs 86.5 crore in FY25 from Rs 70 crore in FY24. With the company’s revenue growth outpacing expense growth, Pee Safe managed to curb its losses by 69% to Rs 4 crore in FY25 from Rs 13 crore in FY24. Its ROCE and EBITDA margin stood at -46.25% and -4.15% respectively. On a unit level, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25, improving from Rs 1.25 in FY24. Pee Safe’s current assets stood at Rs 24 crore, while cash and bank balances were reported at Rs 2 crore during FY25. According to TheKredible, Pee Safe has raised $13.55 million in funding to date, with Alkemi Partners as its lead investor. Its founder & CEO, Vikas Bagaria, owns 11.20% of the company. Either way, the firm is not just close to breakeven, but close to key milestones like the Rs 100 crore mark, profitability and possibly much more, if it can stay focused and deliver on its core promise.

Wellness brand Amocare raises $400K in pre-seed round

EntrackrEntrackr · 1y ago
Wellness brand Amocare raises $400K in pre-seed round
Medial

Wellness brand Amocare has secured $400,000 in a pre-seed funding round co-led by FAAD Network and AngelBay Holdings. The proceeds will be deployed towards scaling business operations, curating more wellness products in the intimate category, building a high-trust brand, and focusing on driving customer awareness, Amocare said in a press release. Launched in 2023 by Prabhat Maheshwari, Amocare offers premium intimate wellness products with a focus on natural solutions. Its products range from personal care to intimate hygiene, catering to holistic wellness needs. According to the company, its products help in combating the rising challenge of lifestyle-related intimacy concerns by offering couples natural, effective, and scientifically formulated solutions. Gurugram-based Amocare claims that it will be expanding its product distribution in the international markets like Eastern Europe and the UK through one of its strategic investors. The other major players in this space are Bold Care, MyMuse, Pee Safe, The Sangya Project and others.

Healthfab raises $1 Mn in pre-Series A round

EntrackrEntrackr · 10m ago
Healthfab raises $1 Mn in pre-Series A round
Medial

Healthfab, a reusable period panty brand, has raised $1 million in its pre-Series A funding round led by Mistry Ventures along with participation from BeyondSeed, Thrive Ventures, and distinguished investors such as Anupam Mittal, Aman Gupta, Vineeta Singh, and Peyush Bansal. Prior to this, the company had raised $336K in a seed round from BeyondSeed back in 2022. The proceeds will be utilized to expand its presence in metro and Tier 2 cities as well as invest in R&D, Healthfab said in a press release. Co-founded in 2019 by Kiriti Acharjee, Sourav Chakrabarty, and Satyajit Chakraborty, Healthfab aims to transform menstrual hygiene with convenient, comfortable, and eco-friendly solutions. The company weeds out the challenges faced by women in their families. The startup’s innovative GoPadFree Period Panty is a reusable, leak-proof solution that offers comfort, unrestricted movement, and eliminates plastic waste. It is designed for confidence and ease. According to market research, India’s feminine hygiene industry is projected to reach $2 billion by 2030 with a growing CAGR of 14.8% (2025-2030). Healthfab claims that it has become the first reusable period panty brand in India to receive BIS certification and patent protection for its innovative technology. It also states to have acquired more than 3 lakh customers along with an annual growth rate of 2.5-3x in revenue. It competes with other players in this space such as Thinx and Knix.

Exclusive: Kapiva raises $10 Mn from existing investors

EntrackrEntrackr · 1y ago
Exclusive: Kapiva raises $10 Mn from existing investors
Medial

Homegrown D2C ayurvedic nutrition brand Kapiva has raised Rs 83.5 crore (approximately $10 million) led by OrbiMed Asia with the participation of 3One4 Capital and Vertex Ventures. The board at Kapiva has passed a special resolution to issue 5,62,631 compulsory convertible preference shares to raise the aforementioned sum, its regulatory filing sourced from the Registrar of Companies shows. OrbiMed Asia led the round with Rs 52.2 crore, while 3One4 Capital and Vertex Ventures participated with Rs 11.96 crore and Rs 19.33 crore, respectively. The fresh funding appears to be part of Kapiva’s Series C round, in which the firm is aiming to raise a total of Rs 250 crore. Entrackr exclusively reported about Kapiva’s Series C round in Nov 2022. With the fresh tranche, the firm has raised Rs 132 crore in the ongoing round. It had already raised Rs 48.75 crore ($6 million) in Series C from OrbiMed and other existing investors back in October 2022. Kapiva has also increased its ESOP size by adding 1,415,00 new employee stock, bringing the total ESOP pool to 4,47,741, separate filing shows. As per the Entrackr estimates, its ESOP pool size is now worth Rs 66 crore. Kapiva will use these funds for the expansion and development of the company. Kaviva has raised over $30 million to date and has notable investors including Jetty Ventures, Fireside, OrbiMed, 3One4Capital, and others. According to the startup data intelligence platform TheKredible, the company has been valued at around $80 million post-allotment. Founded in 2015, Kapiva is an ayurvedic nutrition brand that offers natural and organic health and skincare products for hair fall, weight loss, digestion, diabetes in the form of juices, tea, oils, shakes et al. During the fiscal year ended March 2023, Kaviva registered 87% year-on-year growth to Rs 116.48 crore with a loss standing at Rs 64.5 crore in the same period. Kapiva is yet to file its annual results for FY24. While the D2C ayurveda space is crowded with plenty of organized brands, Upakarma Ayurveda, and Dr. Vaidya’s, Varalife, among others are Kapiva’s notable competitors.

Download the medial app to read full posts, comements and news.